Divis Laboratories drug manufacturers on Saturday submitted a 13 percent increase in its combined profit to Rs 557 crore in the first quarter ending June 30, 2021.
The company reported a total profit of Rs 492 crore in the April-June quarter of the previous budget.
Revenue rose to Rs 1,997 crore in the first half compared to Rs 1,748 crore in the June 2020-21 quarter, Divi’s Laboratories said in a regulatory filing.
Forex current quarterly profit stood at Rs 20 crore compared to Rs 5 crore profit during the quarter corresponding to last year, he adds.
also read : Warren Buffett’s Berkshire Hathaway is recovering from coronavirus problems
also read : Popular Vehicles & Services file IPO documents with Sebi
